WFA
TXG icon

Wipfli Financial Advisors’s 10x Genomics TXG Stock Holding History

Wipfli Financial Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$26K Buy
+929
New +$35.4K ﹤0.01% 1452

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wipfli Financial Advisors's TXG Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in 10x Genomics (TXG) in Q3 2022: 929 shares worth $26K. The stake represents ﹤0.01% of the portfolio and ranks #1452 among its holdings.

233 funds tracked by Wall St. Rank hold TXG as of Q3 2022.

  • Wipfli Financial Advisors held 929 shares of 10x Genomics worth $26K as of Q3 2022.
  • 10x Genomics was a new Wipfli Financial Advisors position in Q3 2022.
  • 10x Genomics made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1452 holding.
  • 233 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.